Jump to main content
Jump to site search

Issue 15, 2018
Previous Article Next Article

nCVTs: a hybrid smart tumour targeting platform

Author affiliations

Abstract

A hybrid drug delivery platform involving the fusion of cell membranes from U937 monocytes and synthetic lipids to create nano-cell vesicle technology systems (nCVTs) is designed. nCVTs are engineered for a targeted approach towards tumour sites by preserving key surface proteins from U937 monocytes, while being amendable to functionalization and loading due to their liposomal components.

Graphical abstract: nCVTs: a hybrid smart tumour targeting platform

Back to tab navigation

Supplementary files

Publication details

The article was received on 22 Nov 2017, accepted on 08 Mar 2018 and first published on 13 Mar 2018


Article type: Communication
DOI: 10.1039/C7NR08720A
Citation: Nanoscale, 2018,10, 6812-6819
  •   Request permissions

    nCVTs: a hybrid smart tumour targeting platform

    W. J. Goh, S. Zou, B. Czarny and G. Pastorin, Nanoscale, 2018, 10, 6812
    DOI: 10.1039/C7NR08720A

Search articles by author

Spotlight

Advertisements